Abstract
Background: Targeting CD20+ melanoma cancer stem cells (CSCs) subset is essential for treating melanoma. Anti-CD20 aptamer-modified exosomes (ACEXO) l......
小提示:本篇文献需要登录阅读全文,点击跳转登录